Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Trump Asks Supreme Court to Pause TikTok Ban Adding Legal Uncertainty to National Security Debate SEC Advances TrumpBacked Proposal to End Mandatory Quarterly Earnings Reports Retirees Face Property Value Risks as Renovation Aversion Depresses Selling Prices Nvidia Shares Decline PostEarnings What Market Participants Might Be Overlooking Q4 Earnings Season Updates EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains BSET Q1 2026 Earnings EPS Falls Short of Estimates Amid Furniture Market Headwinds Atlanta Braves Holdings Inc Series A BATRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid OffSeason Carter Bankshares Inc CARE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Positive Stock Reaction Stardust Power Inc Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges MacroGenics MGNX Q1 2026 Earnings Narrowing Loss on EPS Surprise as Stock Rebounds ZOOZ Strategy Ltd Breaks Out 86 Approaches Key Resistance at 032 ZOOZW Warrants Surge 5789 High Volatility at 003 BitFuFu FUFU Holds Near Support Amid Modest Decline Concentra Group Holdings CON Holds Steady Near Key Resistance After Modest Gain Trump Signals Progress on Iran Nuclear Deal and Strait of Hormuz Reopening Horror Film Obsession Scorches Memorial Day Box Office Signals Summer Movie Momentum Yen Stalls as Retail Investors Remain on Sidelines Amid Market Uncertainty Diamondback Energy Stands to Benefit from Recent Oil Price Volatility XCF Global Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Share Rally TROW Q1 2026 Earnings Strong EPS Beat Amid Quiet Markets i80 Gold Corp IAUX Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress for Gold Developer ASR Q1 2026 Earnings EPS Misses Estimates as Headwinds Impact Performance AI Infrastructure and Energy Plays May Have Outpaced Nvidia in Returns Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment